Therapeutics Built on Ethical Data

​The next generation of medicines will be shaped by AI, and the biological data it's trained on. From biodiversity and ecosystems to human populations, tissues and patients, the quality, diversity and provenance of these datasets will help determine what we can discover.

​Join us for a panel discussion and networking with companies building these datasets, as we explore a central question: How can we generate biological data responsibly, and what could this unlock for medicine?

​We’ll discuss ethical approaches to collecting environmental and human biological data, including consent, ownership and benefit sharing, and how these principles can be built into the foundations of companies developing AI-driven medicines.